Genetic inactivation of the major hereditary breast/ovarian cancer predisposition HR genes BRCA1 or BRCA2, or of other HR genes such as the Rad51 paralogs Rad51C, XRCC2 or XRCC3 biases HR in favor of LTGC [28–34]. The gene discussed is BRCA2; the disease is ovarian cancer.